Acute Myeloid Leukemia (Myeloid Neoplasms) Flashcards

Definition Pathogenesis Classification Morphology Clinical features Prognosis Treatment

1
Q

AML occurs when mutations occur that impedes ______ (maturation/differentiation) of myeloid precursors

A

differentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

immature myeloid blasts accumulate in the bone marrow that causes ________ in the blood

A

cytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the median age for AML to occur?

A

60 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Classify AML

A

AML w/ genetic abberation
AML w/ MDS
AML asso. w/ therapy
AML not specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the mutations occuring in AML arising de novo or in young people?

A

t(8;21) - RUNX1/ETO fusion gene
inv(16) - CBFB/MYH1 fusion gene
t(15;17) - PML/RARA fusion gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What genetic changes occur in MDS related AML?

A

Deletions

Monosomies of 5 and 7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What mutations are related with therapy related AML?

A

t(11q23;v) MLL FUSION GENES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

De novo cases of AML include mutation ________ {inv(16)/FLT3}

A

inv(16)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

inv(16) makes _______ fusion gene

A

CBFB/MYH1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

RUNX1/ETO fusion gene is made by translocation of ______

A

t(8;21)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

t(15;17) is responsible for ________ {MLL fusion genes/PML-RARA fusion gene}

A

PML-RARA fusion gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

________ is responsible for MLL fusion genes

A

t(11q23;v)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MLL fusion genes made by t(11q23;v) are _________ (MDS/therapy) related

A

therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

___________ {t(8;21)/t(9;22)} is associated with de novo AML that makes RUNX1-ETO fusion gene

A

t(8;21)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CBFB/MYH1 is made by _______ {epigenetic changes/t(11q23;v)/inv(16)}

A

inv(16)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name the eight mutations that are associated w/ AML.

A
t(8;21)
inv(16)
t(15;17)
FLT3
t(11q23;v)
epigenetic changes
Cohesion complex
NPM mutation
17
Q

What do we find in the bone marrow of AML patients? (4M)

A
Myeloblasts
Monoblasts
Megakaryocytic differentiation
Marrow fibrosis
Rarely erythroid differentiation is seen
18
Q

What are the characteristics of myeloblasts?

A

Cytoplasm more than lymphoblasts
Auer rods
Azurophilic granules
Peroxidase positive

19
Q

What are the characteristics of monoblasts?

A

No auer rods

Non specific esterase positive

20
Q

What are the lab findings in AML?

A
Blast cells may be variable
they may be absent (aleukemic leukemia - do bone marrow biopsy to confirm)
may be less than 10,000
may be more than 100,000
Anemia
Neutropenia
Thrombocytopenia
21
Q

What are the clinical features of AML?

A

Fatigue
Recurrent infections
Mucocutaneous bleeding and petechiae

22
Q

What is the feature of monocytic variant of AML?

A

Monoblasts invade the skin (leukemia cutis) and gingiva

23
Q

Why does fatigue and infxn occurs in AML

A

Fatigue due to anemia

infxn due to neutropenia

24
Q

Why is there a bleeding tendency in AML?

A

low platelets

Leukemic cells release procoagulants and fibrinolytic factors

25
AML can also present as soft tissue masses. Give some examples
myeloblastoma granulocytic sarcoma chloroma
26
What is the prognosis of t(8;21) type of AML?
it is favourable
27
____% cases of AML are favorable
60%
28
t(15;17) has the best prognosis and is curable by ______ and _______ salts.
ATRA | arsenic salts
29
mutations in ____________ suggest a worse prognosis
kinase FLT3
30
Molecular changes in AML often include | ______ overexpression
CD33
31
Treatment with _________, helps overcome the block in cell differentiation caused by t(15;17) PML-RARA fusion gene
retinoic acid
32
Cell death with release of the granules into | the peripheral blood can cause _______
disseminated intravascular coagulation